The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma
Laoruangroj, Chonlada, Atherton, Pamela J, Wiseman, Gregory A, Ansell, Stephen, Feldman, Andrew L, Schumacher, Peyton, Witzig, Thomas E
Published in Leukemia & lymphoma (01.03.2024)
Published in Leukemia & lymphoma (01.03.2024)
Get more information
Journal Article